ijms-logo

Journal Browser

Journal Browser

Molecular Research on Chronic Kidney Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 20 October 2025 | Viewed by 1174

Special Issue Editor


E-Mail Website
Guest Editor
Westmead Institute for Medical Research, Faculty of Medicine and Health, The University of Sydney, Sydney 00026A, Australia
Interests: arthritis; cancer; cardiovascular diseases; kidney disease; therapeutics

Special Issue Information

Dear Colleagues,

Chronic kidney disease (CKD) is a progressive condition characterized by the gradual loss of kidney function, leading to systemic complications, such as cardiovascular disease (CVD) and mineral bone disorder (CKD-MBD), which are associated with high mortality rates. Traditional risk factors cannot fully explain the high incidence of fatal CVD events in CKD. In CKD, cardiovascular complications are influenced by hypertension, hyperlipidemia, and inflammation, with molecular mechanisms, such as RAAS activation, oxidative stress, and endothelial dysfunction, playing key roles.

Mineral and bone disorders (MBDs) are common in CKD, and emerging evidence indicates a causal relationship between MBD and CVD through mechanisms such as vascular calcification and fibrosis. Thus, understanding the prognostic importance of bone and mineral parameters regarding cardiovascular outcomes and mortality is attracting increasing interest. Molecular research has been pivotal in unraveling the underlying mechanisms driving these complications, aiming to develop effective therapies.

Further, the complex interplay between the kidneys, bones, and heart in kidney dysfunction involves hemodynamic, neurohormonal, and immunological pathways. Future molecular genetic research, including genomic, epigenetic, transcriptomic, and proteomic studies, holds promise for identifying new therapeutic targets and personalized treatment strategies.

This Special Issue aims to explore these molecular mechanisms and potential interventions, offering insights into improving patient outcomes for CKD and its complications.

Dr. Sohel Julovi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • CKD
  • CVD
  • CKD-MBD
  • oxidative stress
  • inflammation
  • fibrosis
  • biochemical markers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 310 KiB  
Article
The Interplay of Prolactin with Inflammatory Nutritional Markers and NT-proBNP in Chronic Kidney Disease
by Crina Claudia Rusu, Diana Moldovan, Alina Potra, Dacian Tirinescu, Maria Ticala, Yuriy Maslyennikov, Andrada Barar, Alexandra Urs, Cosmina Ioana Bondor, Ana Valea and Ina Kacso
Int. J. Mol. Sci. 2025, 26(13), 6347; https://doi.org/10.3390/ijms26136347 - 1 Jul 2025
Viewed by 398
Abstract
In chronic kidney disease (CKD), various disorders occur that worsen with the progression of CKD. These include increased levels of hormones such as adiponectin, leptin, and prolactin, changes in feedback loops and metabolism, and decreased renal clearance, contributing to significant morbidity and mortality. [...] Read more.
In chronic kidney disease (CKD), various disorders occur that worsen with the progression of CKD. These include increased levels of hormones such as adiponectin, leptin, and prolactin, changes in feedback loops and metabolism, and decreased renal clearance, contributing to significant morbidity and mortality. We conducted a cross-sectional observational study on 157 randomly selected patients with various stages of chronic kidney disease, 29% of whom had diabetes. We recorded clinical and usual laboratory data. We determined muscle mass and adipose tissue mass using bioimpedance. In addition, we measured serum prolactin levels, tumor necrosis factor-alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin-1 beta (IL-1β). N-terminal pro-B-type natriuretic peptide (NT-proBNP) was evaluated as a marker of cardiac function. We evaluated the relation between prolactin, TNF-α, IL-6, IL-1β, and NT-proBNP by bivariate and multivariate analysis. In bivariate analysis, we recorded associations of prolactin with inflammatory markers: TNF-α (r = 0.65, p < 0.001), IL-6 (r = 0.66, p < 0.001), and IL-1β (r = 0.25, p = 0.002). In multivariate analysis we observed that serum prolactin values are associated with IL-1β [median (25th–75th percentile): [−0.001 (−0.001; −0.00003), p = 0.037], muscle mass [−0.03 (−0.04; −0.01), p = 0.003], and NT-proBNP [0.0001 (0.0001; 0.0001)] p < 0.001 In conclusion, in chronic kidney disease, prolactin is associated with inflammatory markers (IL-1β, TNF-α, IL-6), and nutritional status. Additionally, prolactin has been linked to NT-ProBNP, a marker of cardiac function. Full article
(This article belongs to the Special Issue Molecular Research on Chronic Kidney Disease)
Show Figures

Graphical abstract

Back to TopTop